Blog Where innovation, insight & ideas combine. Contact Us Ask The Experts Home Blog Translational Pharmaceutics, Dr. Helen Baker, Dr. Vanessa Zann, Drug Development Consulting, Drug Product, Philadelphia, Miami Accelerating Drug Development with Translational Pharmaceutics® Read Now Categories View all categories14C Radiolabeling505(b)(2)AlnwickBioanalysisBiopharmaceuticsBlogCandidate DevelopmentCandidate SelectionCareersClinical PharmacologyClinical Trial ManufacturingClinical Trial SuppliesColleague StoriesCommercial ManufacturingCorporate UpdatesCRDMOData SciencesDenise SuttonDennis HendersonDr. Adam Robinson-MillerDr. Andrew LewisDr. Aruna RailkarDr. Asma PatelDr. Gareth JenkinsDr. Helen BakerDr. Peter ScholesDr. Richard Castledine Dr. Stuart MairDr. Stuart McDougallDr. Vanessa ZannDrug Development ConsultingDrug ProductDrug Product OptimizationDrug Substance to Drug ProductEarly DevelopmentFirst-in-HumanFormulation DevelopmentFreeThink ASAPprimeGamma ScintigraphyGLP-1 TherapeuticsHealthy Volunteer TrialsHelen BakerHigh Potency APIsHuman ADMEIain ShawIan NisbetICP-MSIndustry CollaborationInhalationJohn EntwistleJohn McDermottKevser SevimLate DevelopmentMartin Wing-KingMiamiMicrobiologyModeling and SimulationModified ReleaseNazim KanjiNichole CaparelliNottinghamOmer AlpOncologyOrphan DrugsOrphan RarePaige BellisPediatricsPeptidesPharmacy CompoundingPhase 1 TrialsPhiladelphiaPR&DProject ManagementQuality AssuranceRare DiseasesReadingRegulatoryScientific AchievementsScientific InnovationScintigraphySite SpotlightSolid-State CharacterizationSolubility EnhancementThierry Van NieuwenhoveDrug SubstanceIntegrated ProgramsSustainabilityTranslational Pharmaceutics Publish Date View all time20252024202320222021202020192018 Fulltext search 61 - 65 of 121 results Inhalation, Formulation Development, Martin Wing-KingScientific Poster Spotlight: Development of an X-ray Diffraction Method for the Quantification of API Recrystallized from Amorphous API in a Low-Dose Dry Powder Formulation Used for InhalationInhalation, Formulation Development, Martin Wing-KingScientific Poster Spotlight: Development of an X-ray Diffraction Method for the Quantification of API Recrystallized from Amorphous API in a Low-Dose Dry Powder Formulation Used for InhalationLearn more Data SciencesSpotlight on Clinical Operations at Quotient SciencesData SciencesSpotlight on Clinical Operations at Quotient SciencesLearn more Industry CollaborationIntroducing the Charles River and Quotient Sciences CollaborationIndustry CollaborationIntroducing the Charles River and Quotient Sciences CollaborationLearn more Human ADME, Clinical PharmacologyScientific Poster Spotlight on Human ADME: An Integrated Radiolabeled Study of Nolasiban in Healthy Female SubjectsHuman ADME, Clinical PharmacologyScientific Poster Spotlight on Human ADME: An Integrated Radiolabeled Study of Nolasiban in Healthy Female SubjectsLearn more Formulation Development, Early DevelopmentOvercoming Challenges with Poorly Soluble Molecules in Early DevelopmentFormulation Development, Early DevelopmentOvercoming Challenges with Poorly Soluble Molecules in Early DevelopmentLearn more Pagination First page « First Previous page ‹ Previous … Page 11 Page 12 Page 13 Page 14 Page 15 … Next page Next › Last page Last » Learn more about Quotient Sciences At a Glance We are a drug development and manufacturing accelerator for the global pharmaceutical industry. Learn More Our Locations Access directions and information about our facilities in the US & UK. Browse Locations Careers See what life is like at Quotient Sciences and how you can join our global team. Browse Jobs Get in touch Humanity can't afford to wait, so neither can we. Let's talk
